Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence

被引：0
|
作者：
Murewanhema, Grant [1 ]
Dzobo, Mathias [2 ]
Dzinamarira, Tafadzwa [2 ]
机构：
[1] Univ Zimbabwe, Fac Med & Hlth Sci, Dept Primary Hlth Care Sci, Harare, Zimbabwe
[2] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria 0002, South Africa
来源：
TRANSFUSION CLINIQUE ET BIOLOGIQUE | 2023年 / 30卷 / 01期
关键词：
D O I：
10.1016/j.tracli.2022.09.065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies
    Kenta Noda
    Kouki Matsuda
    Shigehiro Yagishita
    Kenji Maeda
    Yutaro Akiyama
    Junko Terada-Hirashima
    Hiromichi Matsushita
    Satoshi Iwata
    Kazuto Yamashita
    Yusuke Atarashi
    Shunsuke Watanabe
    Nobuyuki Ide
    Tomokazu Yoshida
    Norio Ohmagari
    Hiroaki Mitsuya
    Akinobu Hamada
    [J]. Scientific Reports, 11
  • [42] Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in Guinea
    Grayo, Solene
    Sagno, Houlou
    Diassy, Oumar
    Zogbelemou, Jean-Baptiste
    Kondabo, Sia Jeanne
    Houndekon, Marilyn
    Dellagi, Koussay
    Vigan-Womas, Ines
    Rourou, Samia
    Hamouda, Wafa Ben
    Benabdessalem, Chaouki
    Ahmed, Melika Ben
    Tordo, Noel
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [43] Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
    Lee, Yu-Lin
    Liao, Chia-Hung
    Liu, Po-Yu
    Cheng, Chien-Yu
    Chung, Ming-Yi
    Liu, Chun-Eng
    Chang, Sui-Yuan
    Hsueh, Po-Ren
    [J]. JOURNAL OF INFECTION, 2020, 81 (02) : E55 - E58
  • [44] A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies
    Noda, Kenta
    Matsuda, Kouki
    Yagishita, Shigehiro
    Maeda, Kenji
    Akiyama, Yutaro
    Terada-Hirashima, Junko
    Matsushita, Hiromichi
    Iwata, Satoshi
    Yamashita, Kazuto
    Atarashi, Yusuke
    Watanabe, Shunsuke
    Ide, Nobuyuki
    Yoshida, Tomokazu
    Ohmagari, Norio
    Mitsuya, Hiroaki
    Hamada, Akinobu
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats
    Stranieri, Angelica
    Lauzi, Stefania
    Giordano, Alessia
    Galimberti, Luigi
    Ratti, Gabriele
    Decaro, Nicola
    Brioschi, Federica
    Lelli, Davide
    Gabba, Silvia
    Amarachi, Ndiana Linda
    Lorusso, Eleonora
    Moreno, Ana
    Trogu, Tiziana
    Paltrinieri, Saverio
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (04) : 2089 - 2095
  • [46] Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
    Phelan, Thomas
    Dunne, Jean
    Conlon, Niall
    Cheallaigh, Cliona Ni
    Abbott, W. Mark
    Faba-Rodriguez, Raquel
    Amanat, Fatima
    Krammer, Florian
    Little, Mark A.
    Hughes, Gerry
    Bergin, Colm
    Kerr, Colm
    Sundaresan, Sudharshana
    Long, Aideen
    McCormack, William
    Brady, Gareth
    [J]. VIRUSES-BASEL, 2021, 13 (07):
  • [47] Unexpectedly long persistence of anti-SARS-CoV-2 spike monoclonal antibodies tixagevimab and cilgavimab in immunocompromised patients
    Perrier, Quentin
    Lupo, Julien
    Epaulard, Olivier
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [48] Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
    Eberhardt, Kirsten Alexandra
    Dewald, Felix
    Heger, Eva
    Gieselmann, Lutz
    Vanshylla, Kanika
    Wirtz, Maike
    Kleipass, Franziska
    Johannis, Wibke
    Schommers, Philipp
    Gruell, Henning
    Brensing, Karl August
    Mueller, Roman-Ulrich
    Augustin, Max
    Lehmann, Clara
    Koch, Manuel
    Klein, Florian
    Di Cristanziano, Veronica
    [J]. MICROORGANISMS, 2021, 9 (04)
  • [49] Assessment of anti-SARS-CoV-2 antibodies level in convalescents plasma
    Skorek, Andrzej
    Jazwinska-Curyllo, Anna
    Romanowicz, Aleksandra
    Kwasniewski, Krzysztof
    Narozny, Waldemar
    Tretiakow, Dmitry
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 1130 - 1137
  • [50] RituximabFailed to develop anti-SARS-Cov-2 antibodies: case report
    [J]. Reactions Weekly, 2021, 1884 (1) : 379 - 379
12345